Managing Critical Issues & Risks Across Emerging Markets

We help companies and investors to understand the fast-changing geopolitical environment and engage with local stakeholders, supporting market access and growth.

Market Leadership

Speyside is the leading Corporate Affairs & Public Policy consultancy across Emerging Markets.

Global Presence

Our own local teams on the ground across Asia Pacific, Latin America, Europe, the Middle East & Africa.

Strategic Expertise

Deep expertise and experience working on critical issues for private and public sectors.

Why Speyside

Our specialist global practice groups work seamlessly with our own local teams on-the-ground across Asia Pacific, Europe, Latin America, the Middle East & Africa.

Senior international consultants based in key global emerging market centers, offering unrivaled IP & experience built over multiple decades

The very best local consultants on the ground in offices across all global emerging markets, bringing deep local knowledge and contacts

Business is resourced, structured, and managed to ensure all clients have senior consultancy at all times, focused on commercial goals

Strong track record of delivering multi-country mandates in complex and challenging markets

Panoramic view of Singapore’s financial district at sunrise, with the iconic Merlion statue in the foreground and modern skyscrapers reflected in the bay.

News and insights

View all news
Reputation Management
Speyside Group provides an overview on reputation risk. The analysis sets out three connected disciplines: continuous mapping of inward and outward risk, stakeholder engagement built relationship by relationship rather than aimed at a general public, and issue management.
Read post
Healthcare
Speyside Group provides a strategic perspective on compassionate use regulations across Latin America, Africa, and Asia, mapping how patients with serious or life-threatening conditions access unapproved medicines outside a clinical trial. The analysis compares Brazil's RDC 38/2013, South Africa's Section 21, and Asia's more codified frameworks, and outlines the practical questions multinational pharmaceutical companies must answer before running a program in any given market.
Read post
Healthcare
Speyside Group provides a strategic perspective on how pharmaceutical companies influence healthcare policy in Latin America, mapping the seven principal channels of engagement across the region's leading regulatory and reimbursement bodies. Drawing on CONITEC data, Brazil's Partnerships for Productive Development, and coalition-building work with groups such as ERCAL and ILAR, the analysis shows why evidence generation and multi-stakeholder consensus consistently outperform formal lobbying in this market.
Read post